These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 31885094)

  • 1. DC-AL GAN: Pseudoprogression and true tumor progression of glioblastoma multiform image classification based on DCGAN and AlexNet.
    Li M; Tang H; Chan MD; Zhou X; Qian X
    Med Phys; 2020 Mar; 47(3):1139-1150. PubMed ID: 31885094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification of pseudoprogression and true progression of glioblastoma multiform based on longitudinal diffusion tensor imaging without segmentation.
    Qian X; Tan H; Zhang J; Zhao W; Chan MD; Zhou X
    Med Phys; 2016 Nov; 43(11):5889. PubMed ID: 27806598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deep learning model for discriminating true progression from pseudoprogression in glioblastoma patients.
    Moassefi M; Faghani S; Conte GM; Kowalchuk RO; Vahdati S; Crompton DJ; Perez-Vega C; Cabreja RAD; Vora SA; Quiñones-Hinojosa A; Parney IF; Trifiletti DM; Erickson BJ
    J Neurooncol; 2022 Sep; 159(2):447-455. PubMed ID: 35852738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.
    Verma G; Chawla S; Mohan S; Wang S; Nasrallah M; Sheriff S; Desai A; Brem S; O'Rourke DM; Wolf RL; Maudsley AA; Poptani H
    NMR Biomed; 2019 Feb; 32(2):e4042. PubMed ID: 30556932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of Pseudoprogression from True Progressionin Glioblastoma Patients after Standard Treatment: A Machine Learning Strategy Combinedwith Radiomics Features from T
    Sun YZ; Yan LF; Han Y; Nan HY; Xiao G; Tian Q; Pu WH; Li ZY; Wei XC; Wang W; Cui GB
    BMC Med Imaging; 2021 Feb; 21(1):17. PubMed ID: 33535988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-content image generation for drug discovery using generative adversarial networks.
    Hussain S; Anees A; Das A; Nguyen BP; Marzuki M; Lin S; Wright G; Singhal A
    Neural Netw; 2020 Dec; 132():353-363. PubMed ID: 32977280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiogenomics-Based Risk Prediction of Glioblastoma Multiforme with Clinical Relevance.
    Qian X; Tan H; Liu X; Zhao W; Chan MD; Kim P; Zhou X
    Genes (Basel); 2024 Jun; 15(6):. PubMed ID: 38927654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastoma.
    Akbari H; Rathore S; Bakas S; Nasrallah MP; Shukla G; Mamourian E; Rozycki M; Bagley SJ; Rudie JD; Flanders AE; Dicker AP; Desai AS; O'Rourke DM; Brem S; Lustig R; Mohan S; Wolf RL; Bilello M; Martinez-Lage M; Davatzikos C
    Cancer; 2020 Jun; 126(11):2625-2636. PubMed ID: 32129893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shape constrained fully convolutional DenseNet with adversarial training for multiorgan segmentation on head and neck CT and low-field MR images.
    Tong N; Gou S; Yang S; Cao M; Sheng K
    Med Phys; 2019 Jun; 46(6):2669-2682. PubMed ID: 31002188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma.
    Elshafeey N; Kotrotsou A; Hassan A; Elshafei N; Hassan I; Ahmed S; Abrol S; Agarwal A; El Salek K; Bergamaschi S; Acharya J; Moron FE; Law M; Fuller GN; Huse JT; Zinn PO; Colen RR
    Nat Commun; 2019 Jul; 10(1):3170. PubMed ID: 31320621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining DC-GAN with ResNet for blood cell image classification.
    Ma L; Shuai R; Ran X; Liu W; Ye C
    Med Biol Eng Comput; 2020 Jun; 58(6):1251-1264. PubMed ID: 32221797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas.
    de Godoy LL; Mohan S; Wang S; Nasrallah MP; Sakai Y; O'Rourke DM; Bagley S; Desai A; Loevner LA; Poptani H; Chawla S
    J Transl Med; 2023 Apr; 21(1):287. PubMed ID: 37118754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating pseudoprogression from true progression: analysis of radiographic, biologic, and clinical clues in GBM.
    Rowe LS; Butman JA; Mackey M; Shih JH; Cooley-Zgela T; Ning H; Gilbert MR; Smart DK; Camphausen K; Krauze AV
    J Neurooncol; 2018 Aug; 139(1):145-152. PubMed ID: 29767308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PET.
    Kertels O; Mihovilovic MI; Linsenmann T; Kessler AF; Tran-Gia J; Kircher M; Brumberg J; Monoranu CM; Samnick S; Ernestus RI; Löhr M; Meyer PT; Lapa C
    Clin Nucl Med; 2019 Sep; 44(9):695-701. PubMed ID: 31274552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
    Chen Y; Li Z; Wu G; Yu J; Wang Y; Lv X; Ju X; Chen Z
    Int J Neurosci; 2018 Jul; 128(7):608-618. PubMed ID: 29183170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional network connectivity (FNC)-based generative adversarial network (GAN) and its applications in classification of mental disorders.
    Zhao J; Huang J; Zhi D; Yan W; Ma X; Yang X; Li X; Ke Q; Jiang T; Calhoun VD; Sui J
    J Neurosci Methods; 2020 Jul; 341():108756. PubMed ID: 32380227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Glioblastoma Multiforme Progression via Interpretable Structure-Constrained Graph Neural Networks.
    Song X; Li J; Qian X
    IEEE Trans Med Imaging; 2023 Feb; 42(2):380-390. PubMed ID: 36018877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Pseudoprogression in Glioblastoma: Diagnostic Value of Dynamic O-(2-[18F]fluoroethyl)-L-Tyrosine PET.
    Kebir S; Fimmers R; Galldiks N; Schäfer N; Mack F; Schaub C; Stuplich M; Niessen M; Tzaridis T; Simon M; Stoffels G; Langen KJ; Scheffler B; Glas M; Herrlinger U
    Clin Cancer Res; 2016 May; 22(9):2190-6. PubMed ID: 26673798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biomarkers for pseudo and true progression of GBM based on radiogenomics study.
    Qian X; Tan H; Zhang J; Liu K; Yang T; Wang M; Debinskie W; Zhao W; Chan MD; Zhou X
    Oncotarget; 2016 Aug; 7(34):55377-55394. PubMed ID: 27421136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.